129 related articles for article (PubMed ID: 31653009)
1. Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma.
Imai H; Shimizu K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Tanaka S; Fujita A; Kogure Y; Seki Y; Mogi A; Oyama T; Minato K; Asao T; Kaira K
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31653009
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.
Ohtaki Y; Kaira K; Yajima T; Erkhem-Ochir B; Kawashima O; Kamiyoshihara M; Igai H; Onozato R; Ibe T; Kosaka T; Nakazawa S; Nagashima T; Oyama T; Shirabe K
Thorac Cancer; 2021 Oct; 12(20):2666-2679. PubMed ID: 34453496
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.
Miura Y; Kaira K; Sakurai R; Imai H; Tomizawa Y; Sunaga N; Minato K; Hisada T; Oyama T; Yamada M
Oncol Lett; 2017 Aug; 14(2):2369-2378. PubMed ID: 28789453
[TBL] [Abstract][Full Text] [Related]
4. Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Head Neck; 2016 Oct; 38(10):1539-44. PubMed ID: 27312568
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Tumor Immunity in Surgically Resected Pulmonary Pleomorphic Carcinoma.
Kaira K; Shimizu K; Endoh H; Imaizumi K; Kamiyoshihara M; Sugano M; Kawashima O; Tanaka S; Fujita A; Imai H; Kogure Y; Oyama T; Asao T; Shirabe K
Anticancer Res; 2020 Jan; 40(1):261-269. PubMed ID: 31892575
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Neoplasma; 2016; 63(3):477-83. PubMed ID: 26952514
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.
Imai H; Kaira K; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Kosaka T; Yajima T; Ohtaki Y; Osaki T; Kogure Y; Tanaka S; Fujita A; Oyama T; Minato K; Asao T; Shirabe K
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028659
[TBL] [Abstract][Full Text] [Related]
8. Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer.
Kaira K; Toyoda M; Shimizu A; Mori K; Shino M; Sakakura K; Takayasu Y; Takahashi K; Oyama T; Asao T; Chikamatsu K
Neoplasma; 2016; 63(4):588-94. PubMed ID: 27268922
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic Carcinoma.
Kaira K; Kamiyoshihara M; Kawashima O; Endoh H; Imaizumi K; Sugano M; Tanaka S; Fujita A; Kogure Y; Shimizu A; Oyama T; Asao T; Shimizu K; Mogi A
Anticancer Res; 2019 Jan; 39(1):395-403. PubMed ID: 30591486
[TBL] [Abstract][Full Text] [Related]
10. High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.
Miura Y; Kaira K; Sakurai R; Imai H; Tomizawa Y; Sunaga N; Minato K; Hisada T; Oyama T; Yamada M
Int J Clin Oncol; 2017 Oct; 22(5):872-879. PubMed ID: 28550415
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.
Ogawa H; Kaira K; Takahashi K; Shimizu A; Altan B; Yoshinari D; Asao T; Oyama T
Cancer Biomark; 2017 Sep; 20(3):273-281. PubMed ID: 28854502
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Pathol Oncol Res; 2017 Jan; 23(1):111-116. PubMed ID: 27502501
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy.
Xie Z; Zhen T; Lin Y; Shao N; Kuang X
Gland Surg; 2022 Nov; 11(11):1808-1816. PubMed ID: 36518803
[TBL] [Abstract][Full Text] [Related]
14. Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma.
Kaira K; Toyoda M; Shimizu A; Shino M; Sakakura K; Takayasu Y; Takahashi K; Asao T; Chikamatsu K
Acta Otolaryngol; 2016; 136(1):1-7. PubMed ID: 26366837
[TBL] [Abstract][Full Text] [Related]
15. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
16. Expression of TS, RRM1, ERCC1, TUBB3 and STMN1 Genes in Tissues of Non-small Cell Lung Cancer and its Significance in Guiding Postoperative Adjuvant Chemotherapy.
Zou ZQ; Du YY; Sui G; Xu SN
Asian Pac J Cancer Prev; 2015; 16(8):3189-94. PubMed ID: 25921119
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients.
Lu B; Zhang H; Zhang T; Cai Y; Hu Y; Zheng H; Li B
Thorac Cancer; 2016 Jul; 7(4):486-94. PubMed ID: 27385993
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.
Okuda K; Oda R; Suzuki A; Sakane T; Kawano O; Haneda H; Moriyama S; Nakanishi R
J Thorac Dis; 2017 May; 9(5):1295-1302. PubMed ID: 28616281
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.
Cao Y; Zhang G; Wang P; Zhou J; Gan W; Song Y; Huang L; Zhang Y; Luo G; Gong J; Zhang L
BMC Gastroenterol; 2017 Jan; 17(1):2. PubMed ID: 28056823
[TBL] [Abstract][Full Text] [Related]
20. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
